Mol. Cells 2009; 27(1): 5-14
Published online February 5, 2009
https://doi.org/10.1007/s10059-009-0015-1
© The Korean Society for Molecular and Cellular Biology
The availability of effective vaccines has had the most profound positive effect on improving the quality of public health by preventing infectious diseases. Despite many successful vaccines, there are still old and new emerging pathogens against which there is no vaccine available. A better understanding of how vaccines work for providing protection will help to improve current vaccines as well as to develop effective vaccines against pathogens for which we do not have a proper means to control. Recent studies have focused on innate immunity as the first line of host defense and its role in inducing adaptive immunity; such studies have been an intense area of research, which will reveal the immunological mechanisms how vaccines work for protection. Toll-like receptors (TLRs), a family of receptors for pathogen-associated molecular patterns on cells of the innate immune system, play a critical role in detecting and responding to microbial infections. Importantly, the innate immune system modulates the quantity and quality of long-term T and B cell memory and protective immune responses to pathogens. Limited studies suggest that vaccines which mimic natural infection and/or the structure of pathogens seem to be effective in inducing long-term protective immunity. A better understanding of the similarities and differences of the molecular and cellular events in host responses to vaccination and pathogen infection would enable the rationale for design of novel preventive measures against many challenging pathogens.
Keywords adaptive, immune responses, innate, memory B cells, pathogen, plasma cells, signaling, TLRs, vaccine, VLPs
Mol. Cells 2009; 27(1): 5-14
Published online January 31, 2009 https://doi.org/10.1007/s10059-009-0015-1
Copyright © The Korean Society for Molecular and Cellular Biology.
Sang-Moo Kang, Richard W. Compans
The availability of effective vaccines has had the most profound positive effect on improving the quality of public health by preventing infectious diseases. Despite many successful vaccines, there are still old and new emerging pathogens against which there is no vaccine available. A better understanding of how vaccines work for providing protection will help to improve current vaccines as well as to develop effective vaccines against pathogens for which we do not have a proper means to control. Recent studies have focused on innate immunity as the first line of host defense and its role in inducing adaptive immunity; such studies have been an intense area of research, which will reveal the immunological mechanisms how vaccines work for protection. Toll-like receptors (TLRs), a family of receptors for pathogen-associated molecular patterns on cells of the innate immune system, play a critical role in detecting and responding to microbial infections. Importantly, the innate immune system modulates the quantity and quality of long-term T and B cell memory and protective immune responses to pathogens. Limited studies suggest that vaccines which mimic natural infection and/or the structure of pathogens seem to be effective in inducing long-term protective immunity. A better understanding of the similarities and differences of the molecular and cellular events in host responses to vaccination and pathogen infection would enable the rationale for design of novel preventive measures against many challenging pathogens.
Keywords: adaptive, immune responses, innate, memory B cells, pathogen, plasma cells, signaling, TLRs, vaccine, VLPs
Yosep Mo, Sung-Yoon Kang, Ji-Young Bang, Yujin Kim, Jiung Jeong, Eui-Man Jeong, Hye Young Kim, Sang-Heon Cho, and Hye-Ryun Kang
Mol. Cells 2022; 45(11): 833-845 https://doi.org/10.14348/molcells.2022.0038Ki-Hong Jang, Chloe R. Heras, and Gina Lee
Mol. Cells 2022; 45(7): 435-443 https://doi.org/10.14348/molcells.2022.0017Min Kyung Jung and Eui-Cheol Shin
Mol. Cells 2021; 44(6): 401-407 https://doi.org/10.14348/molcells.2021.0079